Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by MJgroweron Jan 18, 2017 1:22pm

35 Views

Post# 25723635

RE:RE:RE:RE:RE:RE:RE:NF Level 2

And I bet you look forward to making a double or triple soon enough! This stock is way oversold (and over bashed by the local losers lol) and should rise nicely...2017 the year of MJ!!

Eplexx420 wrote: I just bought 133947 shares at 11 cents to get this stock going. You can call me a pumper all you'd like but we're all here to make money. That's the only point. Not here to be your friend.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading